Aim: To compare the long-term clinical outcome of turned vs. moderately rough implants.
Materials And Methods: Patients treated with implants in the edentulous mandible and/or maxilla were invited for a clinical examination. After prosthesis removal, the pocket depth was measured and the bleeding scored. Also, a new radiograph was taken for bone loss evaluation. Patients were also requested to rate their satisfaction with the treatment.
Results: One hundred and ninety-seven implants in 33 patients were evaluated. After a mean follow-up of 172 months (SD 42, range 120-252), the mean loss was 1.61 mm (SD 1.35, range 0.00-8.25). Bone loss was higher in the maxilla compared to the mandible (P < 0.001), and at implants, that was restored on implant level (P = 0.003). Multivariate analyses demonstrated a significant effect of implant surface roughness and time of loading on bone loss. Smoking, on the other hand, did not affect the outcome. Mean pocket probing depth was 3.64 mm (SD 0.96, range 1.25-7.25). A total of 4.1% of the implants demonstrated signs of peri-implantitis. The overall patient satisfaction rate was 98.5%.
Conclusion: Implant treatment in the edentulous jaw has a predictable long-term outcome with limited complications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/clr.12602 | DOI Listing |
Dokl Biochem Biophys
January 2025
Department of Orthopaedics, Affiliated Hospital of Hebei University, 071000, Baoding, China.
Unlabelled: Osteoporosis is a condition where bones weaken due to a loss in density and quality, making them fragile and more susceptible to fractures, even from minor stress or injury. In this experimental study, we scrutinized the antiosteoporosis effect of phyllanthin against glycocorticoid (GIOP) induced osteoporosis in rats.
Methods: : SD rats were used in this study and subcutaneous administration of DEX (3 mg/kg) was used for the induction of osteoporosis and rats were treated with phyllanthin and alendronate for 12 weeks.
Clin Oral Investig
January 2025
Fujian Key Laboratory of Oral Diseases & Stomatological Key lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, Fujian Province, 350002, China.
Objective: Both the Masquelet technique (MT) and concentrated growth factors (CGF) reduce early graft loss and improve bone regeneration. This study aims to explore the efficacy of combining MT with CGF for mandibular defect repair by characterizing the induced membrane and assessing in vivo osteogenesis.
Materials And Methods: Three experimental groups were compared: negative control (NC), MT, and Masquelet combined with CGF (MTC).
Jpn J Radiol
January 2025
Department of Obstetrics and Gynecology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Purpose: This study aimed to investigate whether vitamin K (menatetrenone) suppresses bone mineral density (BMD) loss in the irradiated region after radiotherapy (RT) in uterine cancer patients.
Materials And Methods: Our study included 34 patients who underwent whole pelvic irradiation for uterine cancer between 2001 and 2010. The patients were categorized in two groups: (1) Vitamin K (45 mg/day) administration group (group A) with 18 cases and (2) non-administered group (group B) with 16 cases.
Mol Cell Biochem
January 2025
Department of Orthopaedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Osteoporosis and vascular calcification are chronic metabolic diseases threatening the health of aging people. The incidence of osteoporosis and vascular calcification increases year by year, and has drawn much attention from the scientific and clinical area. Many studies have found that osteoporosis and vascular calcification are not completely independent, but there are close correlations between them in the pathogenesis and underlying mechanisms.
View Article and Find Full Text PDFOper Orthop Traumatol
January 2025
Klinik für Unfall‑, Hand- und Wiederherstellungschirurgie, Universitätsmedizin Rostock, Schillingallee 35, 18057, Rostock, Deutschland.
Objective: Removal of a transcutaneous osseintegrated endo-fix stem (ESKA Orthopaedic, Lübeck, Germany) following a fatigue fracture of the implant, whilst protecting the residual femur bone to allow transcutaneous osseointegrated prosthesis system (TOPS) reimplantation.
Indications: A patient's request for a further TOPS implantation following a fatigue fracture of a circular osseointegrated implant stem.
Contraindications: Impending destruction of the bone tube through mobilisation of the femoral implant stem with insufficient thickness of the cortical wall (< 2-3 mm).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!